Dr. Reddy’s Laboratories Ltd. (DRREDDY): Dr. Reddy’s Laboratories Share Price rises 2.71% today
- September 11, 2026
- Posted by: Harsh Piplani
- Category: News
Dr. Reddy’s Laboratories Share Price is trading at Rs 1,171.75, up 2.71% from the previous close, with market capitalisation at Rs 95,420.61 crore as of 11 September 2026 at 11:53:02 AM IST. The move places DRREDDY among the notable stocks in news in the Indian stock market today. The latest Univest data confirms the price event, but it does not establish a company-specific catalyst. That makes the market read-through more important than any single headline: investors are watching how the healthcare name is behaving relative to its valuation, sector context and peer set. In this Univest stock analysis, the focus is on the price rise, the numbers behind the move and what should stay on the radar next.
Dr. Reddy’s Laboratories Share Price Today: Price Action Analysis
| Metric | Value |
|---|---|
| Current Price | Rs 1,171.75 |
| Previous Close | Rs 1,140.8 |
| Today's Move | Rs 30.95 (+2.71%) |
| Open | Rs 1,132.5 |
| High | Rs 1,174.5 |
| Low | Rs 1,131.05 |
| Turnover | Rs 4.77 crore |
| Market Capitalisation | Rs 95,420.61 crore |
| Market Cap Category | Large Cap |
Dr. Reddy's Laboratories Ltd. (DRREDDY) rose to Rs 1,171.75 from the previous close of Rs 1,140.8, a move of Rs 30.95 or 2.71%. The stock opened at Rs 1,132.5, reached a high of Rs 1,174.5, recorded a low of Rs 1,131.05.
Dr. Reddy’s Laboratories Share Price Today reflects a clear intraday rise. The stock opened at Rs 1,132.50, touched a high of Rs 1,174.50 and a low of Rs 1,131.05, and was last at Rs 1,171.75 versus the previous close of Rs 1,140.80. The change of Rs 30.95 translates into a 2.71% share price gain, while turnover stood at Rs 4.77 crore. The pattern shows steady interest around the stock during the market update, with DRREDDY also drawing attention as a healthcare top gainer today. According to latest Univest figures, the price event is real and measurable; what remains unconfirmed is any company-specific trigger.
Dr. Reddy's Laboratories Ltd. (DRREDDY) Fundamental Analysis
| Metric | Value |
|---|---|
| Market Capitalisation | Rs 95,420.61 crore |
| P/E Ratio | 29.55x |
| P/B Ratio | 2.49x |
| ROE | 11.69% |
| ROCE | 13.75% |
| EPS | Rs 38.6 |
| Book Value Per Share | Rs 457.39 |
| Dividend Yield | 0.7% |
Dr. Reddy's Laboratories Ltd. (DRREDDY) fundamental metrics show P/E 29.55x, P/B 2.49x, ROE 11.69%, ROCE 13.75%. These figures provide context only and are not a buy or sell signal.
Dr. Reddy’s Laboratories Ltd. has a market capitalisation of Rs 95420.61 crore and falls in the Large Cap category, which gives readers a sense of company size before judging valuation. On valuation, P/E at 29.55x, P/B at 2.49x should be read against the sector and peer benchmarks rather than as a standalone signal. Profitability is represented by ROE of 11.69% and ROCE of 13.75%, helping investors compare shareholder returns and capital efficiency. According to latest Univest data, additional metrics include EPS of Rs 38.6, book value per share of Rs 457.39, dividend yield of 0.7%, adding context to earnings, balance-sheet value and historical payout. Against the latest Univest same industry benchmark, these figures can be compared with benchmark median P/E of 32.73x, median ROE of 11.83%, median ROCE of 13.68%. These numbers explain the fundamental backdrop without converting the article into a buy or sell view.
Sector and Industry Context
| Metric | Value |
|---|---|
| Sector | Healthcare |
| Industry | Pharmaceuticals & Drugs |
| Benchmark Scope | same industry |
| Company P/E Ratio | 29.55x |
| Benchmark Median P/E | 32.73x |
| Benchmark Average P/E | 49.1x |
| Benchmark P/E Range | 3.4x to 701.57x |
| Company P/B Ratio | 2.49x |
| Benchmark Median P/B | 3.06x |
| Company ROE | 11.69% |
| Benchmark Median ROE | 11.83% |
| Company ROCE | 13.75% |
| Benchmark Median ROCE | 13.68% |
| Company Market Capitalisation | Rs 95,420.61 crore |
| Benchmark Median Market Cap | Rs 750.93 crore |
Dr. Reddy's Laboratories Ltd. (DRREDDY) is classified under sector: Healthcare and industry: Pharmaceuticals & Drugs.
Dr. Reddy's Laboratories Ltd. (DRREDDY) has a P/E ratio of 29.55x, which is below the benchmark median of 32.73x, a difference of -9.72%. P/E is a valuation multiple and is not, by itself, a buy or sell signal.
Dr. Reddy's Laboratories Ltd. (DRREDDY) has a ROE of 11.69%, which is below the benchmark median of 11.83%, a difference of -1.18%. Dr. Reddy's Laboratories Ltd. (DRREDDY) has a ROCE of 13.75%, which is above the benchmark median of 13.68%, a difference of +0.51%.
Track stocks leading today through the Univest top gainers screener. The peer table below provides the company-level comparison.
Peer Comparison
| Company | Symbol | Market Cap (Cr) | P/E | P/B | ROE (%) | ROCE (%) |
|---|---|---|---|---|---|---|
| Sun Pharmaceutical Industries Ltd. | SUNPHARMA | 4,48,315.74 | 36.98 | 5.17 | 14.85 | 19.11 |
| Divi's Laboratories Ltd. | DIVISLAB | 2,51,737.22 | 85.36 | 14.14 | 16.19 | 21.51 |
| Torrent Pharmaceuticals Ltd. | TORNTPHARM | 1,87,593.62 | 85.95 | 20.89 | 26.76 | 19.27 |
| Zydus Lifesciences Ltd. | ZYDUSLIFE | 1,12,618.18 | 24.71 | 4.14 | 19.69 | 21.39 |
| Cipla Ltd. | CIPLA | 1,10,515.04 | 33.08 | 3.17 | 11.83 | 16 |
Dr. Reddy's Laboratories Ltd. (DRREDDY) has a P/E ratio of 29.55x compared with the displayed peer median of 36.98x. This is a relative valuation comparison, not a buy or sell signal. Its ROE of 11.69% compares with a peer median of 16.19% across the companies shown in the table. ROCE stood at 13.75% versus the displayed peer median of 19.27%, providing a capital-efficiency comparison. Dr. Reddy's Laboratories Ltd. (DRREDDY) has a market capitalisation of Rs 95,420.61 crore. Among the 5 peers shown, 5 have a larger market capitalisation.
Why Investors Are Watching Dr. Reddy’s Laboratories
- The stock is rising today by 2.71%, with Dr. Reddy’s Laboratories Share Price moving from Rs 1,140.80 to Rs 1,171.75.
- The move is supported by a measurable intraday range between Rs 1,131.05 and Rs 1,174.50.
- Dr. Reddy’s Laboratories Share Price Today is backed by a market cap of Rs 95,420.61 crore, which keeps it firmly in the large-cap conversation.
- The P/E of 29.55 and P/B of 2.49 place the stock in a valuation band that investors can compare with the healthcare benchmark and peer set.
- ROE of 11.69%, ROCE of 13.75%, EPS of Rs 38.6, book value of Rs 457.39 and dividend yield of 0.7% add financial context to the price move.
About Dr. Reddy’s Laboratories
Dr. Reddy’s Laboratories Ltd. operates in the Pharmaceuticals & Drugs industry within the Healthcare sector and is one of India’s recognised drug makers. The company is known for working across formulations, active ingredients and related pharmaceutical businesses, which places it in a segment where regulation, product quality, pricing and market access matter materially. For investors tracking Dr. Reddy’s Laboratories Stock News, this business profile is important because the company’s share price often reflects both earnings quality and sector sentiment. Dr. Reddy’s Laboratories Share Price also tends to attract attention because the company has a large market capitalisation and broad market visibility on both NSE and BSE. In Univest coverage, the company is best viewed as a mature healthcare name whose stock performance is influenced by financial ratios, sector comparison and company-specific developments when they are verified.
Frequently Asked Questions
Why is Dr. Reddy's Laboratories Share Price rising today?
Ans. Dr. Reddy's Laboratories Share Price is rising today because the stock traded higher by 2.71% to Rs 1,171.75. The latest Univest data confirms the move, but it does not establish a company-specific catalyst.
What is Dr. Reddy's Laboratories Share Price today?
Ans. Dr. Reddy's Laboratories Share Price Today is Rs 1,171.75. It moved up Rs 30.95 from the previous close of Rs 1,140.80 and traded between Rs 1,131.05 and Rs 1,174.50.
What is Dr. Reddy's Laboratories market cap?
Ans. Dr. Reddy's Laboratories has a market capitalisation of Rs 95,420.61 crore. That places it well above the same-industry median and supports its position as a large healthcare stock in India.
How does Dr. Reddy's Laboratories compare on valuation?
Ans. Dr. Reddy's Laboratories Share Price is backed by a P/E of 29.55 and a P/B of 2.49. Both sit below the same-industry median and average, which is useful for peer reading.
What do Dr. Reddy's Laboratories fundamentals show?
Ans. The company reports ROE of 11.69%, ROCE of 13.75%, EPS of Rs 38.6, book value of Rs 457.39 and dividend yield of 0.7%. These figures help frame the share price rise.
How is Dr. Reddy's Laboratories placed in the healthcare sector?
Ans. Dr. Reddy's Laboratories operates in Healthcare, specifically Pharmaceuticals & Drugs. Its P/E is below the industry median, while ROCE is slightly above the median, giving the stock a balanced sector profile.
Which peers are relevant for Dr. Reddy's Laboratories Share Price comparison?
Ans. Relevant peers include Sun Pharmaceutical Industries Ltd., Divi's Laboratories Ltd., Torrent Pharmaceuticals Ltd., Zydus Lifesciences Ltd. and Cipla Ltd. Their valuation and return ratios provide useful comparison points.
Can investors track Dr. Reddy's Laboratories Share Price Live on Univest?
Ans. Yes. Univest tracks Dr. Reddy's Laboratories Share Price Live, along with company news, valuation ratios, 52-week levels and sector context. That helps readers follow the stock without relying on one headline alone.
Track Dr. Reddy’s Laboratories Share Price on Univest
Use Dr. Reddy's Laboratories Ltd. (DRREDDY) live share-price page, Univest top gainers screener, Univest market blogs to review live stock data, top-gainers lists and related market analysis.
Track Dr. Reddy’s Laboratories Share Price Live on Univest for updates on price movement, company news, market cap, valuation ratios, 52-week levels and broader market insights. Univest also helps readers follow Dr. Reddy’s Laboratories Share News, latest healthcare sector moves and stock performance in one place. If you are scanning Dr. Reddy’s Laboratories Stock Gaining Today or comparing it with other bullish stocks, Univest keeps the context simple and data-led.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).
